Blood-based tumor mutational burden from circulating tumor DNA and immune checkpoint inhibitors in advanced prostate cancer.Grant Rauterkus, Mehmet Asım Bilen, Michael B. Lilly et al.|Journal of Clinical Oncology|2022Cited by 3
2403P LuRa: Efficacy and Tolerability of Radium-223 Following [177Lu]Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate CancerJonathan Zarka, Donald S. Childs, Praful Ravi et al.|Annals of Oncology|2025Cited by 1
Health-related quality of life (HrQoL) of first-line treatments in metastatic renal cell carcinoma (mRCC): A network meta-analysis.Oluseyi Abidoye, Irbaz Bin Riaz, Syed Arsalan Ahmed Naqvi et al.|Journal of Clinical Oncology|2024Cited by 0